Sepsis-Induced Immunosuppression

被引：190

作者：

Torres, Lisa K. ^{[1
]}

Pickkers, Peter ^{[2
]}

van der Poll, Tom ^{[3
]}

机构：

[1] Weill Cornell Med, New York Presbyterian Hosp, Dept Med, Div Pulm & Crit Care Med, New York, NY 10021 USA

[2] Radboud Univ Nijmegen, Dept Intens Care Med, Med Ctr, Nijmegen, Netherlands

[3] Univ Amsterdam, Amsterdam Univ Med Ctr, Ctr Expt & Mol Med, Div Infect Dis, Amsterdam, Netherlands

来源：

ANNUAL REVIEW OF PHYSIOLOGY | 2022年 / 84卷

基金：

欧盟地平线“2020”;

关键词：

TUMOR-NECROSIS-FACTOR; STIMULATING FACTOR THERAPY; PROGRAMMED CELL-DEATH; INTENSIVE-CARE-UNIT; SEPTIC SHOCK; IMPROVES SURVIVAL; T-CELLS; GM-CSF; EPIGENETIC REGULATION; SECONDARY INFECTIONS;

D O I：

10.1146/annurev-physiol-061121-040214

中图分类号：

Q4 [生理学];

学科分类号：

071003 ;

摘要：

Sepsis is expected to have a substantial impact on public health and cost as its prevalence increases. Factors contributing to increased prevalence include a progressively aging population, advances in the use of immunomodulatory agents to treat a rising number of diseases, and immune-suppressing therapies in organ transplant recipients and cancer patients. It is now recognized that sepsis is associated with profound and sustained immunosuppression, which has been implicated as a predisposing factor in the increased susceptibility of patients to secondary infections and mortality. In this review, we discuss mechanisms of sepsis-induced immunosuppression and biomarkers that identify a state of impaired immunity. We also highlight immune-enhancing strategies that have been evaluated in patients with sepsis, as well as therapeutics under current investigation. Finally, we describe future challenges and the need for a new treatment paradigm, integrating predictive enrichment with patient factors that may guide the future selection of tailored immunotherapy.

引用

页码：157 / 181

页数：25

共 142 条

[11] IFN-γ: A cytokine at the right time, is in the right place [J].

Burke, J. Daniel ;

Young, Howard A. .

SEMINARS IN IMMUNOLOGY, 2019, 43

[12] Shared and Distinct Aspects of the Sepsis Transcriptomic Response to Fecal Peritonitis and Pneumonia [J].

Burnham, Katie L. ;

Davenport, Emma E. ;

Radhakrishnan, Jayachandran ;

Humburg, Peter ;

Gordon, Anthony C. ;

Hutton, Paula ;

Svoren-Jabalera, Eduardo ;

Garrard, Christopher ;

Hill, Adrian V. S. ;

Hinds, Charles J. ;

Knight, Julian C. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 196 (03) :328-339

[13] Impact of sepsis on CD4 T cell immunity [J].

Cabrera-Perez, Javier ;

Condotta, Stephanie A. ;

Badovinac, Vladimir P. ;

Griffith, Thomas S. .

JOURNAL OF LEUKOCYTE BIOLOGY, 2014, 96 (05) :767-777

[14] Epigenetic regulation of immune cell functions during post-septic immunosuppression [J].

Carson, William F. ;

Cavassani, Karen A. ;

Dou, Yali ;

Kunkel, Steven L. .

EPIGENETICS, 2011, 6 (03) :273-283

[15] Impaired CD4+ T-cell proliferation and effector function correlates with repressive histone methylation events in a mouse model of severe sepsis [J].

Carson, William F., IV ;

Cavassani, Karen A. ;

Ito, Toshihiro ;

Schaller, Matthew ;

Ishii, Makoto ;

Dou, Yali ;

Kunkel, Steven L. .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2010, 40 (04) :998-1010

[16] Bench-to-bedside review: Endotoxin tolerance as a model of leukocyte reprogramming in sepsis [J].

Cavaillon, Jean-Marc ;

Adib-Conquy, Minou .

CRITICAL CARE, 2006, 10 (05)

[17] The post sepsis-induced expansion and enhanced function of regulatory T cells create an environment to potentiate tumor growth [J].

Cavassani, Karen A. ;

Carson, William F. ;

Moreira, Ana Paula ;

Wen, Haitao ;

Schaller, Matthew A. ;

Ishii, Makoto ;

Lindell, Dennis M. ;

Dou, Yali ;

Lukacs, Nicholas W. ;

Keshamouni, Venkateshwar G. ;

Hogaboam, Cory M. ;

Kunkel, Steven L. .

BLOOD, 2010, 115 (22) :4403-4411

[18] Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis [J].

Chang, Katherine ;

Svabek, Catherine ;

Vazquez-Guillamet, Cristina ;

Sato, Bryan ;

Rasche, David ;

Wilson, Strother ;

Robbins, Paul ;

Ulbrandt, Nancy ;

Suzich, JoAnn ;

Green, Jonathan ;

Patera, Andriani C. ;

Blair, Wade ;

Krishnan, Subramaniam ;

Hotchkiss, Richard .

CRITICAL CARE, 2014, 18 (01)

[19] Anti-PD-1/PD-L1 therapy of human cancer: past, present, and future [J].

Chen, Lieping ;

Han, Xue .

JOURNAL OF CLINICAL INVESTIGATION, 2015, 125 (09) :3384-3391

[20] Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis [J].

Cheng, Shih-Chin ;

Scicluna, Brendon P. ;

Arts, Rob J. W. ;

Gresnigt, Mark S. ;

Lachmandas, Ekta ;

Giamarellos-Bourboulis, Evangelos J. ;

Kox, Matthijs ;

Manjeri, Ganesh R. ;

Wagenaars, Jori A. L. ;

Cremer, Olaf L. ;

Leentjens, Jenneke ;

van der Meer, Anne J. ;

van de Veerdonk, Frank L. ;

Bonten, Marc J. ;

Schultz, Marcus J. ;

Willems, Peter H. G. M. ;

Pickkers, Peter ;

Joosten, Leo A. B. ;

van der Poll, Tom ;

Netea, Mihai G. .

NATURE IMMUNOLOGY, 2016, 17 (04) :406-+

← 1 2 3 4 5 6 7 8 9 10 →